Pediatric Dermatology

New York - When diagnosing a pediatric hair disorder, be sure to examine not only the scalp, but also the skin, nails and even the mouth.

As knowledge increases, physician urges derm advocacy in political, regulatory fields

When treating black patients for hair and scalp disorders, clinicians must also have an understanding of hair care practices.

National report - A large, prospective, six-year clinical trial is well under way to investigate whether early, aggressive treatment of atopic dermatitis in infants can alter the future course of their skin disorder and the development of other manifestations of atopy, particularly asthma.

In dermatology, there are myriad diseases that can be affected by emotional aspects and in which coping with the disease is important.

Charleston, S.C. - Skin diseases are common among pediatric solid organ transplant recipients, and so dermatologists play an important role in the management of these children, said Maria C. Garzon, M.D., at the 2004 annual meeting of the Society for Pediatric Dermatology here.

Better care of infants contributes to decline in diaper rash, cradle cap; psoriasis on the rise

Kona, Hawaii - Tacrolimus ointment is superior to pimecrolimus cream in treating atopic dermatitis, according to recent trial data reported by Alan Fleischer, M.D., during the 28th Annual Hawaii Dermatology Seminar here. Both calcineurin inhibitors have identical modes of action and identical metabolism, and bind to the same FKBP receptor. "But pimecrolimus has one-third the binding affinity of tacrolimus," he says.

The literature also contained three case series that included 13 patients.

Victoria, British Columbia - Antihistamines are effective adjunctive therapy in the treatment of atopic dermatitis (AD), according to research presented at the annual meeting of the Canadian Dermatology Association.

Topical vitamin B12 cream may offer some atopic dermatitis patients a natural alternative to corticosteroids and topical immunomodulators, according to a new study.

New York - The increased pigment in darker skin types helps protect women of color against photodamage, but poses other important cosmetic issues for this patient population, says Valerie D. Callender, M.D.

Internationally recognized researcher, Alan Menter, M.D., considers the future of psoriasis treatment.

Albert Kligman, M.D., Ph.D., is a pioneer who continues to break new ground in dermatology.

Stanford, Calif. - Skin cancer in immunosuppressed solid organ transplant recipients is a significant problem and one of growing importance as patient survival post-transplantation continues to increase, says Daniel Berg, M.D

Many approaches now available to rejuvenate upper, lower face

Dilution, needle selection, patient assessment and proper technique yield quality results

Doctors' expertise grows; patient confidence climbs; options broaden

Uses explode across medical specialties

Victoria, British Columbia - Sometimes what we accept as fact isn't actually reality. The truth in pediatric dermatology is turning out to be a bit different in some conditions than was taken for granted just a few years ago.

Cleveland - When thinking of pediatric fungal diseases, the mind may immediately turn toward the scalp and the typical presentation of tinea capitis. Yet fungal diseases often masquerade in several forms in various areas of the body, making the dermatologist's job of diagnosis and treatment more complicated.

Washington -Allergic contact dermatitis (ACD) has an appreciable, detrimental effect on quality of life, according to the results of a survey presented by Donald V. Belsito, M.D., at the annual meeting of the American Academy of Dermatology.

They are not the most common of dermatitis types that dermatologists typically see in their practices, but asteatotic dermatitis and neurodermatitis are driving some people to seek relief from their doctors.

A controversial report suggests that Britons should sunbathe daily without sunblock to help prevent disease.

The U.S. Food and Drug Administration (FDA) is warning the public about "adverse events" associated with some "permanent" makeup treatments.